This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Progressive ascending telangiectasia (PAT)

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • progressive ascending telangiectasia (PAT) is a rare disease characterized by the development of telangiectatic vessels, initially limited to the feet and ankles, and later spreading up to the legs and onto the trunk and arms
    • the disorder is characterized by the development of telangiectasias which appear initially on the distal lower extremities but slowly and progressively spread to involve the trunk, arms, and face
  • women are the most commonly affected, with an average age of onset in the fourth decade of life
  • diagnosis is clinical, once other primary and secondary causes of telangiectasias have been excluded
  • typical evolution makes it possible to distinguish it from the general group of essential telangiectasia

  • systemic treatment with tetracyclines, ketoconazole, and acyclovir has been reported to have been effective in some cases (1,2), and a focal clotting process within the capillaries of the skin, induced by candidal or bacterial endotoxin antigens has been advocated as a pathogenic mechanism (3)
    • only isolated cases treated with each of the above-mentioned drugs have been published, so these cannot be considered as generally accepted treatment measures
    • other therapeutic options include sclerosing therapies, e.g. polydocanol, and pulsed dye laser (585 nm) (3,4)

Reference:

  • 1. Shelley WB, Fierer JA. Focal intra-vascular coagulation in progressive ascending telangiectasia: ultrastructural studies of ketoconazole-induced involution of vessels. J Am Acad Dermatol 1984; 10 (5): 876-877
  • 2. Shelley WB, Shelley ED. Essential progressive telangiectasia in an autoimmune setting: successful treatment with acyclovir. J Am Acad Dermatol 1989;21(5): 1094-1096.
  • 3. Buscaglia DA, Conte ET. Successful treatment of generalised essential telangiectasia with the 585-nm flash lamp-pumped pulsed dye laser. Cutis 2001;67(2): 107-108.
  • 4. Seiter S et al. An oculocutaneous presentation of essential progressive telangiectasia.British Journal of Dermatology 1999; 140 (5): 969-971.

Related pages

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.